pioglitazone has been researched along with Candidemia in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Candidemia: A form of invasive candidiasis where species of CANDIDA are present in the blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Majer, O | 1 |
Bourgeois, C | 1 |
Zwolanek, F | 1 |
Lassnig, C | 1 |
Kerjaschki, D | 1 |
Mack, M | 1 |
Müller, M | 1 |
Kuchler, K | 1 |
1 other study available for pioglitazone and Candidemia
Article | Year |
---|---|
Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections.
Topics: Animals; Antigens, CD; Antigens, Ly; Candida albicans; Candidemia; Candidiasis; Chemokine CCL2; Chem | 2012 |